{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:17:32Z","timestamp":1794874652811,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF16OC0019302"],"award-info":[{"award-number":["NNF16OC0019302"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Infections have become the major cause of morbidity and mortality among patients with chronic lymphocytic leukemia (CLL) due to immune dysfunction and cytotoxic CLL treatment. Yet, predictive models for infection are missing. In this work, we develop the CLL Treatment-Infection Model (CLL-TIM) that identifies patients at risk of infection or CLL treatment within 2 years of diagnosis as validated on both internal and external cohorts. CLL-TIM is an ensemble algorithm composed of 28 machine learning algorithms based on data from 4,149 patients with CLL. The model is capable of dealing with heterogeneous data, including the high rates of missing data to be expected in the real-world setting, with a precision of 72% and a recall of 75%. To address concerns regarding the use of complex machine learning algorithms in the clinic, for each patient with CLL, CLL-TIM provides explainable predictions through uncertainty estimates and personalized risk factors.<\/jats:p>","DOI":"10.1038\/s41467-019-14225-8","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T11:03:05Z","timestamp":1579258985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Machine learning can identify newly diagnosed patients with CLL at high risk of infection"],"prefix":"10.1038","volume":"11","author":[{"given":"Rudi","family":"Agius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brieghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9729-9974","authenticated-orcid":false,"given":"Michael A.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2801-7456","authenticated-orcid":false,"given":"Alexander T.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ledergerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cozzi-Lepri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-6148","authenticated-orcid":false,"given":"Yoram","family":"Louzoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christen L.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9279-6936","authenticated-orcid":false,"given":"Jacob","family":"Bergstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob H.","family":"von Stemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-0560","authenticated-orcid":false,"given":"Mette","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3483-0219","authenticated-orcid":false,"given":"Man-Hung Eric","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Bahlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen D.","family":"Herling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-7850","authenticated-orcid":false,"given":"Jens","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron Ross","family":"MacPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-5242","authenticated-orcid":false,"given":"Carsten U.","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"14225_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.105","volume":"6","author":"C da Cunha-Bang","year":"2016","unstructured":"da Cunha-Bang, C. et al. Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients. Blood Cancer J. 6, e499 (2016).","journal-title":"Blood Cancer J."},{"key":"14225_CR2","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","volume":"376","author":"M Hallek","year":"2010","unstructured":"Hallek, M. et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 376, 1164\u20131174 (2010).","journal-title":"Lancet"},{"key":"14225_CR3","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJMoa1313984","volume":"370","author":"V Goede","year":"2014","unstructured":"Goede, V. et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N. Engl. J. Med. 370, 1101\u20131110 (2014).","journal-title":"N. Engl. J. Med."},{"key":"14225_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1470-2045(14)71182-9","volume":"16","author":"MZH Farooqui","year":"2015","unstructured":"Farooqui, M. Z. H. et al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. Lancet Oncol. 16, 169\u2013176 (2015).","journal-title":"Lancet Oncol."},{"key":"14225_CR5","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek, M. et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131, 2745\u20132760 (2018).","journal-title":"Blood"},{"key":"14225_CR6","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.3324\/haematol.2018.197889","volume":"103","author":"MA Andersen","year":"2018","unstructured":"Andersen, M. A. & Niemann, C. U. Immune failure, infection and survival in chronic lymphocytic leukemia in Denmark. Haematologica 103, e330 (2018).","journal-title":"Haematologica"},{"key":"14225_CR7","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.3324\/haematol.2018.196543","volume":"103","author":"KR Crassini","year":"2018","unstructured":"Crassini, K. R., Best, O. G. & Mulligan, S. P. Immune failure, infection and survival in chronic lymphocytic leukemia. Haematologica 103, e329 (2018).","journal-title":"Haematologica"},{"key":"14225_CR8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S1470-2045(16)30051-1","volume":"17","author":"B Eichhorst","year":"2016","unstructured":"Eichhorst, B. et al. First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol. 17, 928\u2013942 (2016).","journal-title":"Lancet Oncol."},{"key":"14225_CR9","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1182\/blood-2005-12-051458","volume":"109","author":"WG Wierda","year":"2007","unstructured":"Wierda, W. G. et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood 109, 4679\u20134685 (2007).","journal-title":"Blood"},{"key":"14225_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2141.2011.08974.x","volume":"156","author":"C Pepper","year":"2012","unstructured":"Pepper, C. et al. Defining the prognosis of early stage chronic lymphocytic leukaemia patients. Br. J. Haematol. 156, 499\u2013507 (2012).","journal-title":"Br. J. Haematol."},{"key":"14225_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","volume":"17","author":"International CLL-IPI working group.","year":"2016","unstructured":"International CLL-IPI working group. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol. 17, 779\u2013790 (2016).","journal-title":"Lancet Oncol."},{"key":"14225_CR12","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","volume":"121","author":"JC Riches","year":"2013","unstructured":"Riches, J. C. et al. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood 121, 1612\u20131621 (2013).","journal-title":"Blood"},{"key":"14225_CR13","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","volume":"96","author":"JA Burger","year":"2000","unstructured":"Burger, J. A. et al. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96, 2655\u20132663 (2000).","journal-title":"Blood"},{"key":"14225_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","volume":"117","author":"Y Herishanu","year":"2011","unstructured":"Herishanu, Y. et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117, 563\u2013574 (2011).","journal-title":"Blood"},{"key":"14225_CR15","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1038\/leu.2013.131","volume":"27","author":"SEM Herman","year":"2013","unstructured":"Herman, S. E. M. et al. Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy. Leukemia 27, 2311\u20132321 (2013).","journal-title":"Leukemia"},{"key":"14225_CR16","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1182\/blood-2010-12-324210","volume":"117","author":"D Bagnara","year":"2011","unstructured":"Bagnara, D. et al. A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood 117, 5463\u20135472 (2011).","journal-title":"Blood"},{"key":"14225_CR17","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1158\/1078-0432.CCR-15-1965","volume":"22","author":"CU Niemann","year":"2016","unstructured":"Niemann, C. U. et al. Disruption of in vivo chronic lymphocytic leukemia tumor-microenvironment interactions by ibrutinib\u2013findings from an investigator-initiated phase II Study. Clin. Cancer Res. 22, 1572\u20131582 (2016).","journal-title":"Clin. Cancer Res."},{"key":"14225_CR18","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1158\/1078-0432.CCR-15-3106","volume":"22","author":"P Bachireddy","year":"2016","unstructured":"Bachireddy, P. & Wu, C. J. Arresting the inflammatory drive of chronic lymphocytic leukemia with Ibrutinib. Clin. Cancer Res. 22, 1547\u20131549 (2016).","journal-title":"Clin. Cancer Res."},{"key":"14225_CR19","doi-asserted-by":"crossref","unstructured":"Pleyer, C. et al. Partial reconstitution of humoral and cellular immunity in patients with chronic lymphocytic leukemia treated with acalabrutinib. 132, 1874\u20131874 (2018).","DOI":"10.1182\/blood-2018-99-111919"},{"key":"14225_CR20","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","volume":"121","author":"D Rossi","year":"2013","unstructured":"Rossi, D. et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 121, 1403\u20131412 (2013).","journal-title":"Blood"},{"key":"14225_CR21","first-page":"52","volume":"100","author":"P Baliakas","year":"2015","unstructured":"Baliakas, P. et al. Refining prognosis of chronic lymphocyticleukemia with somatically hypermutated B-cell receptors: a novel prognosticindex on behalf of the european research initiative on CLL (ERIC). Haematologica 100, 52\u201352 (2015).","journal-title":"Haematologica"},{"key":"14225_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/ajh.24660","volume":"92","author":"J Delgado","year":"2017","unstructured":"Delgado, J. et al. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI. Am. J. Hematol. 92, 375\u2013380 (2017).","journal-title":"Am. J. Hematol."},{"key":"14225_CR23","unstructured":"Danish National Research Foundation. Precision medicine and bioinformatics with 320 mph: when data sharing increases the understanding of diseases. DNRF. https:\/\/dg.dk\/en\/precision-medicine-and-bioinformatics-with-320-mph-when-data-sharing-increases-the-understanding-of-diseases\/ (2017)."},{"key":"14225_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.seminoncol.2016.02.009","volume":"43","author":"SA Parikh","year":"2016","unstructured":"Parikh, S. A. & Shanafelt, T. D. Prognostic factors and risk stratification in chronic lymphocytic leukemia. Semin. Oncol. 43, 233\u2013240 (2016).","journal-title":"Semin. Oncol."},{"key":"14225_CR25","doi-asserted-by":"publisher","first-page":"e8392","DOI":"10.1097\/MD.0000000000008392","volume":"96","author":"P-E Fournier","year":"2017","unstructured":"Fournier, P.-E. et al. Blood culture-negative endocarditis: improving the diagnostic yield using new diagnostic tools. Medicine 96, e8392 (2017).","journal-title":"Medicine"},{"key":"14225_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1128\/JCM.01679-15","volume":"54","author":"H Salimnia","year":"2016","unstructured":"Salimnia, H. et al. Evaluation of the filmarray blood culture identification panel: results of a multicenter controlled trial. J. Clin. Microbiol. 54, 687\u2013698 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"14225_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3770-2","volume":"11","author":"P-Y Iroh Tam","year":"2018","unstructured":"Iroh Tam, P.-Y. et al. Detection of Streptococcus pneumoniae from culture-negative dried blood spots by real-time PCR in Nigerian children with acute febrile illness. BMC Res. Notes 11, 657 (2018).","journal-title":"BMC Res. Notes"},{"key":"14225_CR28","doi-asserted-by":"crossref","unstructured":"Sivic & Zisserman. Video Google: a text retrieval approach to object matching in videos. Proc. Ninth IEEE Int. Conf. Comput. Vision 2, 1470\u20131477 (2003).","DOI":"10.1109\/ICCV.2003.1238663"},{"key":"14225_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1145\/65943.65945","volume":"7","author":"V Raghavan","year":"1989","unstructured":"Raghavan, V., Bollmann, P. & Jung, G. S. A critical investigation of recall and precision as measures of retrieval system performance. ACM Trans. Inf. Syst. 7, 205\u2013229 (1989).","journal-title":"ACM Trans. Inf. Syst."},{"key":"14225_CR30","doi-asserted-by":"publisher","first-page":"e0118432","DOI":"10.1371\/journal.pone.0118432","volume":"10","author":"T Saito","year":"2015","unstructured":"Saito, T. & Rehmsmeier, M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS ONE 10, e0118432 (2015).","journal-title":"PLoS One"},{"key":"14225_CR31","unstructured":"Lundberg, S. M. & Lee, S.-I. A Unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst. 4765\u20134774 (2017)."},{"key":"14225_CR32","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle, R. N. et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94, 1840\u20131847 (1999).","journal-title":"Blood"},{"key":"14225_CR33","unstructured":"Van Der Maaten, L. & Hinton, G. Viualizing data using t-SNE. J. Machin. Learning Res. 9, 2579\u20132605 (2008)."},{"key":"14225_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.21105\/joss.00861","volume":"3","author":"L McInnes","year":"2018","unstructured":"McInnes, L., Healy, J., Saul, N. & Gro\u00dfberger, L. UMAP: uniform manifold approximation and projection. JOSS 3, 861 (2018).","journal-title":"JOSS"},{"issue":"1","key":"14225_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"Etienne Becht","year":"2018","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38\u201344 (2018).","journal-title":"Nature Biotechnology"},{"key":"14225_CR36","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.3324\/haematol.2017.182006","volume":"103","author":"MA Andersen","year":"2018","unstructured":"Andersen, M. A. et al. Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study. Haematologica 103, e300\u2013e303 (2018).","journal-title":"Haematologica"},{"key":"14225_CR37","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2147\/CLEP.S99486","volume":"8","author":"C da Cunha-Bang","year":"2016","unstructured":"da Cunha-Bang, C. et al. The danish national chronic lymphocytic leukemia registry. Clin. Epidemiol. 8, 561\u2013565 (2016).","journal-title":"Clin. Epidemiol."},{"key":"14225_CR38","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1182\/blood-2016-07-724740","volume":"128","author":"C da Cunha-Bang","year":"2016","unstructured":"da Cunha-Bang, C., Christiansen, I. & Niemann, C. U. The CLL-IPI applied in a population-based cohort. Blood 128, 2181\u20132183 (2016).","journal-title":"Blood"},{"key":"14225_CR39","unstructured":"Bishop, C. M. Pattern Recognition And Machine Learning (Springer, 2006)."},{"key":"14225_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1109\/MSP.2007.4286565","volume":"24","author":"R Polikar","year":"2007","unstructured":"Polikar, R. Bootstrap - inspired techniques in computation intelligence. IEEE Signal Process. Mag. 24, 59\u201372 (2007).","journal-title":"IEEE Signal Process. Mag."},{"key":"14225_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1214\/ss\/1032280214","volume":"11","author":"TJ DiCiccio","year":"1996","unstructured":"DiCiccio, T. J. & Efron, B. Bootstrap confidence intervals. Stat. Sci. 11, 189\u2013212 (1996).","journal-title":"Stat. Sci."},{"key":"14225_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bjh.15146","volume":"181","author":"KR Crassini","year":"2018","unstructured":"Crassini, K. R. et al. Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia. Br. J. Haematol. 181, 97\u2013101 (2018).","journal-title":"Br. J. Haematol."},{"key":"14225_CR43","doi-asserted-by":"publisher","unstructured":"Towards trustable machine learning. Nat. Biomed. Eng. 2, 709\u2013710. https:\/\/doi.org\/10.1038\/s41551-018-0315-x (2018).","DOI":"10.1038\/s41551-018-0315-x"},{"key":"14225_CR44","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/CCO.0b013e3283589950","volume":"24","author":"JA Burger","year":"2012","unstructured":"Burger, J. A. Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscape. Curr. Opin. Oncol. 24, 643\u2013649 (2012).","journal-title":"Curr. Opin. Oncol."},{"key":"14225_CR45","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.semcancer.2013.09.001","volume":"23","author":"CU Niemann","year":"2013","unstructured":"Niemann, C. U. & Wiestner, A. B-cell receptor signaling as a driver of lymphoma development and evolution. Semin. Cancer Biol. 23, 410\u2013421 (2013).","journal-title":"Semin. Cancer Biol."},{"key":"14225_CR46","doi-asserted-by":"crossref","unstructured":"Perrone, M. P. & Cooper, L. N. in How We Learn; How We Remember: Toward an Understanding of Brain and Neural Systems 342\u2013358 (World Scientific, 1995).","DOI":"10.1142\/9789812795885_0025"},{"key":"14225_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.inffus.2004.04.004","volume":"6","author":"G Brown","year":"2005","unstructured":"Brown, G., Wyatt, J., Harris, R. & Yao, X. Diversity creation methods: a survey and categorisation. Inf. Fusion 6, 5\u201320 (2005).","journal-title":"Inf. Fusion"},{"key":"14225_CR48","doi-asserted-by":"publisher","first-page":"1930702","DOI":"10.1155\/2017\/1930702","volume":"2017","author":"K-W Hsu","year":"2017","unstructured":"Hsu, K.-W. A theoretical analysis of why hybrid ensembles work. Comput. Intell. Neurosci. 2017, 1930702 (2017).","journal-title":"Comput. Intell. Neurosci."},{"key":"14225_CR49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-3-540-25966-4_29","volume":"3077","author":"P Melville","year":"2004","unstructured":"Melville, P., Shah, N., Mihalkova, L. & Mooney, R. Experiments on ensembles with missing and noisy data. Lecture Notes Comput. Sci. 3077, 293\u2013302 (2004).","journal-title":"Lecture Notes Comput. Sci."},{"key":"14225_CR50","unstructured":"Shui, C., Mozafari, A., Marek, J., Hedhli, I. & Gagn\u00e9, C. Diversity regularization in deep ensembles. Preprint at arXiv https:\/\/arxiv.org\/abs\/1802.07881 (2018)."},{"key":"14225_CR51","doi-asserted-by":"crossref","unstructured":"Wang, S. & Yao, X. Diversity analysis on imbalanced data sets by using ensemble models. in Proc. IEEE Symp. Comput. Intell. Data Mining (IEEE, 2009).","DOI":"10.1109\/CIDM.2009.4938667"},{"key":"14225_CR52","unstructured":"Baraldi, P., Razavi-Far, R. & Zio, E. A method for estimating the confidence in the identification of nuclear transients by a bagged ensemble of FCM classifiers. in Proc. NPIC&HMIT.\u00a0283\u2013293 (2010)."},{"key":"14225_CR53","doi-asserted-by":"crossref","unstructured":"Muhlbaier, M., Topalis, A. & Polikar, R. in Multiple Classifier Systems Vol. 3541 (eds Oza, N. C., Polikar, R., Kittler, J. & Roli, F.) 326\u2013335 (Springer, 2005).","DOI":"10.1007\/11494683_33"},{"key":"14225_CR54","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00277-018-3350-5","volume":"97","author":"S Molica","year":"2018","unstructured":"Molica, S., Giannarelli, D., Mirabelli, R., Levato, L. & Shanafelt, T. D. Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis. Ann. Hematol. 97, 2005\u20132008 (2018).","journal-title":"Ann. Hematol."},{"key":"14225_CR55","unstructured":"Persimune. Danish National Foundation for Research\u2019s (DNRF) centre of excellence (COE) for personalised medicine of infectious complications in immune deficiency (PERSIMUNE). http:\/\/www.persimune.dk (2019)."},{"key":"14225_CR56","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41551-018-0304-0","volume":"2","author":"SM Lundberg","year":"2018","unstructured":"Lundberg, S. M. et al. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat. Biomed. Eng. 2, 749\u2013760 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"14225_CR57","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol, E. J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 25, 44\u201356 (2019).","journal-title":"Nat. Med."},{"key":"14225_CR58","doi-asserted-by":"crossref","unstructured":"Dietterich & Thomas, G. Ensemble Methods in Machine Learning (Springer-Verlag, 2000).","DOI":"10.1007\/3-540-45014-9_1"},{"key":"14225_CR59","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1109\/34.58871","volume":"12","author":"LK Hansen","year":"1990","unstructured":"Hansen, L. K. & Salamon, P. Neural network ensembles. IEEE Trans. Pattern Anal. Mach. Intell. 12, 993\u20131001 (1990).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"14225_CR60","doi-asserted-by":"crossref","unstructured":"Breiman, L. Random Forests. Mach. Learn. 45, 5\u201332 (2001).","DOI":"10.1023\/A:1010933404324"},{"key":"14225_CR61","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. XGBoost: a scalable tree boosting system. in Proc. 22nd ACM SIGKDD Int. Conf. Knowledge Discov. Data Mining (ACM Press, 2016).","DOI":"10.1145\/2939672.2939785"},{"key":"14225_CR62","first-page":"2825","volume":"12","author":"Fabian Pedregosa","year":"2011","unstructured":"Pedregosa, Fabian et al. Scikit-learn: machine learning in Python %J. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"14225_CR63","first-page":"123","volume":"24","author":"Leo Breiman","year":"1996","unstructured":"Breiman, Leo. Bagging predictors. Mach. Learn. 24, 123\u2013140 (1996).","journal-title":"Mach. Learn."},{"key":"14225_CR64","doi-asserted-by":"crossref","unstructured":"Holland & John, H. Adaptation in Natural and Artificial Systems. (MIT Press, 1992).","DOI":"10.7551\/mitpress\/1090.001.0001"},{"issue":"22","key":"14225_CR65","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1182\/blood.V128.22.4401.4401","volume":"128","author":"Valentin Goede","year":"2016","unstructured":"Bahlo, J. et al. Evaluation of the international prognostic index for chronic lymphocytic leukemia (CLL-IPI) in elderly patients with comorbidities: analysis of the CLL11 Study Population. Blood 128, 4401\u20134401 (2016).","journal-title":"Blood"},{"key":"14225_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-018-0029-1","volume":"1","author":"A Rajkomar","year":"2018","unstructured":"Rajkomar, A. et al. Scalable and accurate deep learning with electronic health records. npj Digital Med. 1, 18 (2018).","journal-title":"npj Digital Med."},{"key":"14225_CR67","unstructured":"Lundberg, S. M., Erion, G. G. & Lee, S.-I. Consistent individualized feature attribution for tree ensembles. Preprint at arXiv https:\/\/arxiv.org\/abs\/1802.03888 (2018)."},{"key":"14225_CR68","doi-asserted-by":"crossref","unstructured":"Ribeiro, M. T., Singh, S. & Guestrin, C. Why should I trust you?: Explaining the predictions of any classifier. in Proc. 22nd ACM SIGKDD Int. Conf. Knowledge Discov. Data Mining (ACM Press, 2016).","DOI":"10.1145\/2939672.2939778"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14225-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14225-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14225-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:04:25Z","timestamp":1670259865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14225-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14225"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-14225-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"4 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.N. has received consultancy fees and\/or travel grants from Janssen, Abbvie, Novartis, Roche, Gilead, Sunesis, Acerta, AstraZeneca, and CSL Behring, research support from Abbvie, AstraZeneca, and Janssen, outside this project. C.D.H. received research funding and travel support from Roche. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}